drugset / Trial / NCT03651947
Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Xgeva® in Healthy Adults
RandomizedParallel-groupTriple-blindPrevention
Summary
A randomized, double-blind and parallel group study to compare the pharmacokinetic, safety and pharmacodynamic of QL1206 and Xgeva® in healthy adults.
Timeline
- Start
- 2018-08-20
- Primary completion
- 2018-11-17
- Completion
- 2019-05-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Denosumab | Monoclonal antibody | 120 mg | Subcutaneous |
Indications
No indication recorded.